IL9 and B-cell chronic lymphocytic leukemia: Abnormal IL-9 secretion by leukemic cells of CLL patients [17, 30–32] and Eμ-TCL1 mice [17] correlates with aggressive disease hallmarks, such as unmutated IGHV, low p66Shc levels [15, 17], and lower overall survival [17].